Dyne Therapeutics to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference
September 27, 2021 07:30 ET
|
Dyne Therapeutics, Inc.
WALTHAM, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living...
Todos Medical Receives Approval by Amazon to Sell Immune Supplements Tollovid® & Tollovid Daily™
September 27, 2021 07:30 ET
|
Todos Medical Ltd.
Tollovid® and Tollovid Daily™ are now available for immediate purchase on Amazon.com New York, NY, and Tel Aviv, ISRAEL, Sept. 27, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd....
Collaboration Between Parties and Levels of Government Key to Housing Affordability in Canada
September 27, 2021 07:30 ET
|
British Columbia Real Estate Association
Vancouver, BC, Sept. 27, 2021 (GLOBE NEWSWIRE) -- With another minority government headed to Ottawa after this month’s federal election, collaboration between parties will be key to a functional...
iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update
September 27, 2021 07:30 ET
|
iBio, Inc.
Expanded Immuno-Oncology Pipeline with License of Next-Gen anti-CD25 Antibody for Solid Tumors Paired Access to RubrYc’s Antibody Discovery Platform with FastPharming® and GlycaneeringTM...
Light Tower Market Worth Over $6 Billion by 2027, Says Global Market Insights Inc.
September 27, 2021 07:30 ET
|
Global Market Insights Inc.
SELBYVILLE, Del., Sept. 27, 2021 (GLOBE NEWSWIRE) -- The light tower market revenue is set to surpass USD 6 billion by 2027, as reported in the latest study by Global Market Insights Inc....
Plus Therapeutics to Present at the Benzinga Healthcare Small Cap Conference
September 27, 2021 07:30 ET
|
Plus Therapeutics Inc.
AUSTIN, Texas, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics...
Crinetics Pharmaceuticals to Unveil its Parathyroid Hormone Receptor Antagonist Program at the American Society for Bone and Mineral Research Annual Meeting
September 27, 2021 07:30 ET
|
Crinetics Pharmaceuticals, Inc.
- Late-breaking Poster Presentation on Sunday, October 3, 2021 SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company...
Ayr Wellness Adds to Florida Footprint with Opening of New Dispensary in Port Richey
September 27, 2021 07:30 ET
|
Ayr Wellness Inc.
MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator (“MSO”), today announced...
Sinclair Technologies Launches the IntelliSENSE™ Series of Power Monitoring System
September 27, 2021 07:30 ET
|
Sinclair Technologies
AURORA, Ontario, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Sinclair Technologies ("Sinclair" or "the Company"), a division of Norsat International and a leading provider of customizable land mobile radio...
Intra-Cellular Therapies Announces Publication of Lumateperone Pivotal Phase 3 Study in Bipolar Depression in The American Journal of Psychiatry
September 27, 2021 07:30 ET
|
Intra-Cellular Therapies Inc.
In this study, lumateperone 42 mg showed significant reduction in depressive symptoms compared to placebo in patients with a major depressive episode associated with bipolar I or bipolar II disorder...
- September 27, 2024 00:00 ET Redefining the “Health or Wealth” Dilemma through HealthFi with Dynachain
- September 26, 2024 23:54 ET The Open Art by Blum, TONX, and TON Society Draws 11,280+ Registered Attendees, Becoming the Largest Event of Token2049 Week